Antibiotic pharmacodynamics /
Saved in:
| Imprint: | New York : Human Press : Springer, ©2016. |
|---|---|
| Description: | 1 online resource (xi, 666 pages) : illustrations (some color) |
| Language: | English |
| Series: | Methods in pharmacology and toxicology, 1940-6053 Methods in pharmacology and toxicology. |
| Subject: | |
| Format: | E-Resource Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11254388 |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | 11254388 | ||
| 005 | 20210625184905.8 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 160404s2016 nyua ob 001 0 eng d | ||
| 015 | |a GBB8M4829 |2 bnb | ||
| 016 | 7 | |a 101688663 |2 DNLM | |
| 016 | 7 | |a 019140367 |2 Uk | |
| 019 | |a 946011664 |a 949649077 |a 961848892 |a 964861436 |a 967614843 |a 981112093 |a 1005824411 | ||
| 020 | |a 9781493933235 |q (electronic bk.) | ||
| 020 | |a 149393323X |q (electronic bk.) | ||
| 020 | |z 9781493933211 | ||
| 020 | |z 1493933213 | ||
| 035 | |a (OCoLC)945924905 |z (OCoLC)946011664 |z (OCoLC)949649077 |z (OCoLC)961848892 |z (OCoLC)964861436 |z (OCoLC)967614843 |z (OCoLC)981112093 |z (OCoLC)1005824411 | ||
| 035 | 9 | |a (OCLCCM-CC)945924905 | |
| 037 | |a com.springer.onix.9781493933235 |b Springer Nature | ||
| 040 | |a RML |b eng |e pn |c RML |d RML |d TMC |d GW5XE |d OCLCF |d OCLCQ |d YDXCP |d QCL |d YDX |d COO |d VT2 |d CAUOI |d BUF |d OCLCQ |d OCLCA |d UAB |d OCLCO |d MERER |d OCLCO |d OTZ |d STF |d OCLCO |d OCLCA |d OCLCQ |d U3W |d UKMGB |d OCLCQ |d OCLCO |d OCLCA | ||
| 049 | |a MAIN | ||
| 050 | 4 | |a QP801.A63 |a RM300 | |
| 060 | 4 | |a QV 268 | |
| 072 | 7 | |a RM |2 lcco | |
| 245 | 0 | 0 | |a Antibiotic pharmacodynamics / |c edited by John C. Rotschafer, David R. Andes, Keith A. Rodvold. |
| 260 | |a New York : |b Human Press : |b Springer, |c ©2016. | ||
| 300 | |a 1 online resource (xi, 666 pages) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Methods in pharmacology and toxicology, |x 1940-6053 | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | 0 | |t General concepts of pharmacodynamics for anti-infective agents / |r Johan W. Mouton -- |t In vitro pharmacodynamic models to evaluate anti-infective pharmacodynamics / |r Warren Rose -- |t Animal models to evaluate anti-infective pharmacodynamics / |r Alexander J. Lepak and David R. Andes -- |t Pharmacodynamic issues in antibiotic combinations / |r Zackery P. Bulman, Ryan C. Dillon, and Brian T. Tsuji -- |t Methodologies for protein binding determination in anti-infective agents / |r Jatinder Kaur Mukker, Ravi Shankar Prasad Singh, and Hartmut Derendorf -- |t Evaluation of exposure-response relationships using clinical data : basic concepts and applications / |r Sujata M. Bhavnani, Christopher M. Rubino, and Paul G. Ambrose -- |t Toxicokinetics and toxicodynamics of anti-infective agents / |r David E. Nix -- |t Pharmacodynamics of fluoroquinolones / |r Ramy H. Elshaboury, Thomas J. Dilworth, and John C. Rotschafer -- |t Aminoglycoside pharmacodynamics / |r Dana R. Bowers, Amy N. Schilling, and Vincent H. Tam -- |t Polymyxin pharmacokinetics and pharmacodynamics / |r Soon-Ee Cheah [and others] -- |t Vancomycin pharmacodynamics : optimal vs. controversial / |r Ben M. Lomaestro -- |t Pharmacodynamics of lipoglycopeptides / |r Eric Wenzler, Siyun Liao, and Keith A. Rodvold -- |t Pharmacodynamics of daptomycin / |r Eric Wenzler, Siyun Liao, and Keith A. Rodvold -- |t Pharmacodynamics of macrolides, azalides, and ketolides / |r Wonhee So and David P. Nicolau -- |t Antifungal pharmacokinetics and pharmacodynamics / |r William Hope and David R. Andes -- |t Pharmacokinetics and pharmacodynamics of the tuberculosis drugs / |r Aline B. Barth, Eric F. Egelund, and Charles A. Peloquin -- |t Pharmacodynamics of antimalarial agents / |r Rahul P. Bakshi and Theresa A. Shapiro -- |t Pharmacodynamics of antiviral agents / |r Renee-Claude Mercier, Bernadette Jakeman, and Larry Pineda -- |t Pharmacodynamics of antiretroviral agents / |r Kajal B. Larson and Edward P. Acosta -- |t Implementing a continuous or prolonged infusion beta-lactam program in the hospital setting / |r Shawn H. MacVane [and others] -- |t Pharmacodynamic considerations in critically ill patients / |r Mahipal G. Sinnollareddy and Jason A. Roberts -- |t Pharmacodynamic considerations and special populations : pediatrics / |r Jennifer Le and John S. Bradley -- |t Pharmacodynamics and obesity / |r Manjunath P. Pai -- |t Drug development process and regulatory science / |r Evelyn J. Ellis-Grosse and Jogarao Gobburu -- |t Antibiotic stewardship and applications of pharmacodynamics / |r Elizabeth D. Hermsen and Lynne Fehrenbacher. |
| 588 | 0 | |a Online resource (Springer Protocols, viewed April 4, 2016). | |
| 520 | 8 | |a Annotation |b This text offers state of the art contributions written by world renown experts which provide an extensive background on specific classes of antibiotics and summarize our understanding as to how these antibiotics might be optimally used in a clinical situation. | |
| 650 | 0 | |a Drugs |x Physiological effect. |0 http://id.loc.gov/authorities/subjects/sh85039742 | |
| 650 | 0 | |a Antibiotics |x Physiological effect. |0 http://id.loc.gov/authorities/subjects/sh85005640 | |
| 650 | 1 | 2 | |a Anti-Bacterial Agents |x pharmacology. |
| 650 | 7 | |a Medical |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Pharmacology. |2 bicssc | |
| 650 | 7 | |a Antibiotics |x Physiological effect. |2 fast |0 (OCoLC)fst00810431 | |
| 650 | 7 | |a Drugs |x Physiological effect. |2 fast |0 (OCoLC)fst00898862 | |
| 700 | 1 | |a Rotschafer, John C. |0 http://id.loc.gov/authorities/names/n2016188052 | |
| 700 | 1 | |a Andes, David R. |0 http://id.loc.gov/authorities/names/n2016188053 | |
| 700 | 1 | |a Rodvold, Keith. |0 http://id.loc.gov/authorities/names/n84205275 | |
| 776 | 0 | 8 | |i Print version: |t Antibiotic pharmacodynamics. |z 9781493933211 |
| 830 | 0 | |a Methods in pharmacology and toxicology. |x 1557-2153 |0 http://id.loc.gov/authorities/names/n2001001798 | |
| 903 | |a HeVa | ||
| 929 | |a oclccm | ||
| 999 | f | f | |i e73cfc21-5025-5889-92bb-28823dd262d6 |s bc922b95-eaaf-5f9e-bded-427a78c092ec |
| 928 | |t Library of Congress classification |a QP801.A63 |l Online |c UC-FullText |u https://link.springer.com/10.1007/978-1-4939-3323-5 |z Springer Nature |g ebooks |i 12536101 | ||